|
|
|
|
LEADER |
01582nam a2200337 u 4500 |
001 |
EB001999842 |
003 |
EBX01000000000000001162743 |
005 |
00000000000000.0 |
007 |
tu||||||||||||||||||||| |
008 |
210907 r ||| eng |
100 |
1 |
|
|a Wells, Charlotte
|
245 |
0 |
0 |
|a Clozapine initiation for schizophrenia
|h Elektronische Ressource
|b a review of clinical effectiveness and guidelines
|c Charlotte Wells, Suzanne McCormack
|
250 |
|
|
|a Version: 1.0
|
260 |
|
|
|a Ottawa (ON)
|b Canadian Agency for Drugs and Technologies in Health
|c 2020, January 28, 2020
|
300 |
|
|
|a 1 PDF file (35 pages)
|b illustration
|
505 |
0 |
|
|a Includes bibliographical references
|
653 |
|
|
|a Adult
|
653 |
|
|
|a Schizophrenia / drug therapy
|
653 |
|
|
|a Canada
|
653 |
|
|
|a Drug Monitoring
|
653 |
|
|
|a Clozapine / therapeutic use
|
653 |
|
|
|a Treatment Outcome
|
653 |
|
|
|a Practice Guidelines as Topic
|
700 |
1 |
|
|a McCormack, Suzanne
|e [author]
|
710 |
2 |
|
|a Canadian Agency for Drugs and Technologies in Health
|
041 |
0 |
7 |
|a eng
|2 ISO 639-2
|
989 |
|
|
|b NCBI
|a National Center for Biotechnology Information
|
490 |
0 |
|
|a CADTH rapid response report: summary with critical appraisal
|
856 |
4 |
0 |
|u http://www.ncbi.nlm.nih.gov/books/NBK562945
|3 Volltext
|n NLM Bookshelf Books
|3 Volltext
|
082 |
0 |
|
|a 610
|
520 |
|
|
|a The objective of the current review is to summarize clinical effectiveness of clozapine during the initiation phase of treatment in adult patients with schizophrenia and summarize recommendations regarding monitoring of adult patients during this initiation phase
|